Beta-Glucan Market Is Projected To Grow Robustly

Beta-Glucan Market Summary

The global beta glucan market size was valued at USD 569.8 million in 2022 and is projected to reach USD 1,055.4 million by 2030, growing at a CAGR of 8.0% from 2023 to 2030. The growth of the market is primarily driven by the increasing use of beta glucan as an immunity booster in the pharmaceutical and nutraceutical industries. Its proven health benefits, particularly in supporting immune function, have made it a preferred ingredient in dietary supplements, functional foods, and health-oriented beverages, thereby boosting its adoption globally.

Changing consumer preferences toward natural and nutritious food supplements over synthetic ingredients are expected to further propel industry growth. In addition, growing awareness among manufacturers regarding the utilization of multiple sources, along with advances in harvesting, processing, and extraction methods, is enhancing product quality and efficiency. Companies are increasingly investing in innovative and patented technologies to differentiate their products, improve market share, and drive overall sales. These technological advancements also allow manufacturers to develop customized beta glucan formulations for diverse applications, including functional foods, beverages, and pharmaceuticals.

Key Market Trends & Insights

• Europe dominated the market and accounted for the largest revenue share of 36.6% in 2022, supported by high consumer awareness, well-established nutraceutical and pharmaceutical sectors, and increasing health-consciousness among the population.
• The Asia Pacific region, on the other hand, is expected to expand at the fastest CAGR of 9.5% during the forecast period, driven by rising disposable incomes, urbanization, and increasing adoption of health supplements across countries such as China, India, and Japan.
• By application, the food and beverages segment held the largest revenue share of 35.5% in 2022, reflecting the high use of beta glucan in functional foods, fortified beverages, and bakery products.
• By product, the soluble beta glucan segment accounted for the larger revenue share of around 61.4% in 2022, due to its superior bioavailability, ease of incorporation into formulations, and widespread health benefits.
• By source, the cereal segment held the largest revenue share of 34.1% in 2022, as cereals such as oats and barley are widely used for extracting beta glucan, given their abundance and functional properties.

Order a free sample PDF of the Beta-Glucan Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2022 Market Size: USD 569.8 Million
• 2030 Projected Market Size: USD 1,055.4 Million
• CAGR (2023-2030): 8.0%
• Europe: Largest market in 2022

Key Companies & Market Share Insights

The market is highly competitive, with a large number of manufacturers accounting for a majority of the market share. Product launches, approvals, strategic acquisitions, and innovations are some of the important business strategies used by market participants to maintain and expand their global reach.

Key Players

• Biotec Pharmacon ASA
• Biothera Pharmaceticals
• Ceapro Inc.
• Immunomedics
• Super Beta Glucan Inc.
• DSM NV
• Tate & Lyle plc (Tate & Lyle Oat Ingredients)
• Groupe Soufflet SA (AIT Ingredients)
• Zilor Inc (Biorigin)
• Cargill Incorporated
• Frutarom
• GlycaNova AS
• Lesaffre Human Care
• Garuda International, Inc.
• Millipore Sigma

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The global beta glucan market is poised for robust growth as consumers increasingly prefer natural, immune-boosting ingredients in food, beverages, and supplements. Europe remains the largest market due to high awareness and established nutraceutical industries, while Asia Pacific is expected to expand at the fastest rate driven by rising health consciousness and disposable income. Soluble beta glucan and cereal-based sources dominate the market, supported by superior bioavailability and accessibility. Ongoing innovation in processing, extraction, and formulation techniques allows manufacturers to develop diverse applications, positioning the market for sustained growth. Overall, rising health awareness and product versatility will continue to drive expansion through 2030.